|Targeted Medical Pharma, Inc.|
2980 Beverly Glen Circle
United States - Map
Targeted Medical Pharma, Inc., a biotechnology company, doing business as Physician Therapeutics, develops and distributes prescription medical foods, convenience-packed products, and generic pharmaceuticals to physicians and pharmacies in the United States. It develops prescription medical foods for the treatment of chronic disease, including pain syndromes, obesity, sleep disorders associated with anxiety, cognitive disorders, peripheral neuropathy, hypertension, viral infections, and joint disorders. The company also provides convenience-packed products, including therapies for pain syndromes, sleep disorders, hypertension, viral infections, and metabolic syndrome, as well as a proprietary billing process and supporting software (PDRx) that facilitates physician dispensing, provides inventory control, and assists regulatory reporting. In addition, it offers billing and collection services relating to its products on behalf of dispensing physician clients to private insurance, Medicare, and workers compensation insurance. Targeted Medical Pharma, Inc. sells its products through a network of distributors and directly to physicians who dispense medical foods and other pharmaceutical products through their office practices. The company was formerly known as Targeted Medical Foods and changed its name to Targeted Medical Pharma, Inc. in 2006. Targeted Medical Pharma, Inc. was founded in 1996 and is headquartered in Los Angeles, California.
|Mr. Kim Giffoni ,
Chief Exec. Officer and Director
|Mr. William B. Horne ,
Chief Financial Officer and Principal Accounting Officer
|Mr. Douglas P. Gintz ,
Chief Technology and Information Officer
|Dr. David Samuel Silver M.D.,
Chief Medical Officer and Director
| Lynette Gebler ,
Chief Compliance & Ethics Officer, Director of Clinical Appeals and Corp. Sec.
|Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|